Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02179697
Other study ID # 2014H0100
Secondary ID
Status Withdrawn
Phase N/A
First received June 16, 2014
Last updated January 14, 2017
Start date August 2014
Est. completion date June 2018

Study information

Verified date January 2017
Source Ohio State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare surgery plus bracing versus bracing alone. Both groups are considered standard of care treatments. The goal of this study is to determine which group is a better treatment.


Description:

Patient must be between 18 and 65 years old and had an acute trauma with an AO type A3 burst fracture (a spinal injury where one of the bony parts of the spine [vertebra] breaks due to immediate and severe compression).

The purpose of this study is to compare surgery plus bracing versus bracing alone. Patients will be followed for 10 years. The investigators will compare patients' x-ray outcomes and clinical outcomes (i.e. how a patient is feeling and how a patient is able to do usual daily activities) as well as patients' immediate and delayed medical and surgical side effects between the 2 study arms. The goal of this study is to determine if treating patients with surgery plus bracing is better than just bracing alone.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date June 2018
Est. primary completion date June 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

1. Age 18-65 years

2. Acute trauma patient with AO Type A3.1-A3.3 fractures of T10-L2

3. Neurologically intact

4. TLICS score of 4

5. Women of childbearing potential must have a negative serum pregnancy test

Exclusion Criteria:

1. Severe poly-trauma (Injury Severity Score >15 and/or intubation required for > 24 hours)

2. Sepsis and/or organ failure

3. Prior instrumented arthrodesis of the thoracolumbar spine

4. Severe co-morbidities (e.g., heart, respiratory, or renal disease)

5. Recent history (<3 years) of concomitant spinal tumor or infection

6. Greater than single level fracture involvement (other than transverse process fractures)

7. AO Type A3 fracture with associated load sharing score =7

8. = 30 degrees regional kyphosis on standing

9. History of autoimmune (seronegative) spondyloarthropathy (i.e., ankylosing spondylitis)

10. History of osteoporosis

11. Subjects who are pregnant or plan to become pregnant in the next 24 months. Patients will be advised on the use of contraceptives during this time. Methods include abstinence or two acceptable forms including condoms with spermicide, birth control pills, injections, or an IUD.

12. Co-morbidity requiring medication that may interfere with bone or soft tissue healing (i.e., oral or parenteral glucocorticoids, NSAIDs immunosuppressive agents, methotrexate)

13. Severe morbid obesity (BMI > 40)

14. History of metal sensitivity/foreign body sensitivity

15. History of prior laminectomy at the fracture site

16. Associated scoliotic (> 10°) or pre-existing thoracolumbar kyphotic deformity

17. History of substance abuse (recreational drugs, prescription drugs or alcohol) that could interfere with protocol assessments and/or with the subject's ability to complete the protocol required follow-up

18. Prisoner

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Patient's Choice
Patient chooses between surgery plus bracing or bracing alone. The patient will be followed according to the same schedule as Group 1.
Procedure:
Surgery + Bracing vs. Bracing Alone
Surgery + Bracing vs. Bracing Alone

Locations

Country Name City State
United States The Ohio State Unviersity Columbus Ohio

Sponsors (1)

Lead Sponsor Collaborator
H Francis Farhadi

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Compare radiologic outcomes using regional kyphosis and Evaluate clinical outcomes using questionnaires Primary Outcome is to compare radiologic and clinical outcomes. These will be measured by regional kyphosis, at 2 years following either non-operative or operative management of thoracolumbar AO type A3.1, A3.2, A3.3 fractures in neurologically-intact patients; and Oswestry Disability Index, at 2 years following either non-operative or operative management of thoracolumbar AO type A3.1, A3.2, A3.3 fractures in neurologically-intact patients. 2 years
Secondary Compare radiologic outcomes using regional kyphosis Secondary outcome is to compare radiologic outcomes, as measured by regional kyphosis, at 5 and 10 years following either non-operative or operative management of thoracolumbar AO type A3.1, A3.2, A3.3 fractures in neurologically-intact patients 5 and 10 years
Secondary Evaluate clinical outcomes using questionnaires Secondary outcome is to evaluate clinical outcomes, as measured by the Oswestry Disability Index, at 5 and 10 years following either non-operative or operative management of thoracolumbar AO type A3.1, A3.2, A3.3 fractures in neurologically-intact patients. 5 and 10 years
Secondary Compare global sagittal balance at 3 different time points Secondary Outcome is to compare global sagittal balance at 2, 5, and 10 years. 2,5, and 10 years
Secondary Collect data on patient in both groups for 10 years Secondary Outcome is to record frequency and time to secondary surgical intervention among patients in the bracing group. 10 years
Secondary Compare Return to work rates over a two year peiord Secondary Outcome is to Compare return-to-work rates at 3 months, 1 year, and 2 years following either non-operative or operative management of thoracolumbar AO type A3.1, A3.2, A3.3 fractures in neurologically-intact patients. 3 month, 1 year, and 2 years
Secondary Compare Health Care Cost between both groups over 10 years Secondary Outcome is to compare health care cost and utilization through extended follow-up period. 10 years
See also
  Status Clinical Trial Phase
Terminated NCT02931266 - PASS MIS® Post-market Clinical Follow-up
Completed NCT02566655 - Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis Phase 1
Unknown status NCT00290862 - A Safety and Efficacy Study for Treatment of Painful Vertebral Compression Fractures Caused by Osteoporosis N/A
Completed NCT04956588 - Evaluation of the Safety and Efficacy of Smart Orthopedic Minimally Invasive Surgical Systems for Spinal Surgery Phase 3
Completed NCT04201678 - Effectiveness of Erector Spinae Block in Kyphoplasty N/A
Completed NCT02931279 - PASS OCT® Post-market Clinical Follow-up
Completed NCT02950532 - Posterior Ligament Complex Assessment Without Magnetic Resonance Image in Thoracolumbar Fractures
Completed NCT02839057 - Survival After Surgical Treatment of Axis Fractures in Elderly N/A
Completed NCT02719340 - Short Segment Fixation in Thoracolumbar Osteoporotic Fracture N/A
Completed NCT02826889 - Assessing the Diagnostic Accuracy of Corrected Flow Time (FTc) and Pleth Variability Index (PVI) as Predictors of Fluid Responsiveness in Patients in the Prone Position Using the Jackson Table N/A
Recruiting NCT02768675 - Intra-operative Assessment of the Intellirod LOADPRO Spinal Rod Strain Sensor for Use During Kyphotic Corrective Surgery N/A
Completed NCT00211237 - CAFE Study - Cancer Patient Fracture Evaluation N/A
Recruiting NCT02784782 - Thoracolumbar Burstfractures, Orthesis or No Orthesis Phase 4
Withdrawn NCT04325165 - DBS of PPN to Improve Walking in Chronic SCI Patients N/A
Completed NCT01123512 - The Kiva® System as a Vertebral Augmentation Treatment Phase 3
Withdrawn NCT00594321 - Evaluation of Fracture Fixation With Energy and Cement in Tumors of the Spine N/A
Not yet recruiting NCT02603874 - The Development of a Vertebra Localizing Aid Medical Device N/A
Completed NCT01761084 - Build Better Bones With Exercise N/A
Completed NCT02840695 - Effect of Biological Disease Modifying Anti Rheumatic Drug (bDMARD) Treatment on Spinal Fracture Incidence in Patients With Ankylosing Spondylitis (AS) N/A
Completed NCT02657265 - SpineJack® Versus Conservative Treatment Study (SPICO Study) N/A